
  
    
      
        Introduction_NNP
        Positive_JJ end-expiratory_JJ pressure_NN (_( PEEP_NNP )_) is_VBZ an_DT important_JJ
        component_NN of_IN the_DT ventilatory_NN management_NN of_IN acute_JJ lung_NN
        injury_NN (_( ALI_NNP )_) and_CC acute_JJ respiratory_JJ distress_NN syndrome_NN
        (_( ARDS_NNP )_) ._. PEEP_NNP improves_VBZ oxygenation_NN by_IN redistributing_VBG the_DT
        alveolar_NN fluid_JJ and_CC restores_NNS functional_JJ residual_JJ capacity_NN by_IN
        keeping_VBG the_DT alveoli_NN open_JJ ._. However_RB ,_, PEEP_NNP can_MD be_VB detrimental_JJ
        because_IN it_PRP may_MD ,_, particularly_RB at_IN high_JJ levels_NNS ,_, decrease_VB
        cardiac_JJ output_NN by_IN decreasing_VBG the_DT venous_JJ return_NN as_IN a_DT result_NN
        of_IN diminished_VBN pressure_NN gradient_NN between_IN the_DT systemic_JJ veins_NNS
        and_CC right_JJ atrium_NN [_NN 1_CD ]_NN ,_, and_CC consequently_RB it_PRP may_MD lead_VB to_TO
        hypoperfusion_NN of_IN vital_JJ organs_NNS ._. Ultimately_RB ,_, despite_IN
        improving_VBG arterial_NN oxygen_NN content_NN ,_, PEEP_NNP may_MD decrease_VB oxygen_NN
        delivery_NN to_TO various_JJ organs_NNS ,_, among_IN which_WDT the_DT splanchnic_JJ
        vascular_NN bed_NN appears_VBZ to_TO be_VB particularly_RB at_IN risk_NN because_IN of_IN
        its_PRP$ predisposing_VBG features_NNS and_CC the_DT influence_NN of_IN PEEP_NNP on_IN
        regional_JJ blood_NN flow_NN distribution_NN ._.
        Maintenance_NNP of_IN splanchnic_JJ blood_NN flow_NN is_VBZ important_JJ
        because_IN splanchnic_JJ hypoperfusion_NN may_MD play_VB a_DT critical_JJ role_NN
        in_IN the_DT pathogenesis_NNS of_IN multiorgan_NN dysfunction_NN syndrome_NN [_NN 2_CD
        3_CD ]_NN ._. Mechanical_NNP ventilation_NN has_VBZ been_VBN suggested_VBN to_TO
        potentiate_NN the_DT adverse_JJ effects_NNS of_IN underlying_VBG critical_JJ
        illness_NN on_IN splanchnic_JJ vasculature_NN and_CC contribute_VB to_TO the_DT
        development_NN of_IN multiorgan_NN dysfunction_NN syndrome_NN ,_,
        particularly_RB when_WRB '_POS injurious_JJ '_POS ventilatory_NN strategies_NNS that_WDT
        produce_VBP high_JJ end-inspiratory_JJ lung_NN volumes_NNS are_VBP employed_VBN [_NN 3_CD
        ]_NN ._. Experimental_NNP studies_NNS suggested_VBD that_IN mechanical_JJ
        ventilation_NN with_IN considerably_RB high_JJ levels_NNS of_IN PEEP_NNP can_MD lead_VB
        to_TO splanchnic_JJ hypoperfusion_NN and_CC marked_VBD reduction_NN in_IN hepatic_JJ
        blood_NN flow_NN [_NN 4_CD 5_CD 6_CD ]_NN ._. Furthermore_RB ,_, PEEP_NNP may_MD decrease_VB
        splanchnic_JJ blood_NN flow_NN in_IN patients_NNS with_IN no_DT underlying_VBG lung_NN
        disease_NN [_NN 7_CD 8_CD ]_NN ._. Most_JJS available_JJ evidence_NN regarding_VBG the_DT
        effects_NNS of_IN PEEP_NNP from_IN animal_NN studies_NNS has_VBZ been_VBN extrapolated_VBN
        to_TO humans_NNS based_VBN on_IN the_DT assumption_NN that_IN the_DT effects_NNS of_IN
        mechanical_JJ ventilation_NN on_IN humans_NNS and_CC animals_NNS are_VBP similar_JJ ._.
        However_RB ,_, a_DT recent_JJ study_NN conducted_VBN in_IN humans_NNS explored_JJ the_DT
        effect_NN of_IN PEEP_NNP in_IN patients_NNS with_IN ALI_NNP [_NN 9_CD ]_NN and_CC did_VBD not_RB find_VB
        a_DT consistent_JJ effect_NN on_IN splanchnic_JJ blood_NN flow_NN ._.
        Because_IN of_IN the_DT difficulties_NNS associated_VBN with_IN measurement_NN
        of_IN pressure-volume_JJ curves_NNS ,_, incremental_JJ titration_NN of_IN PEEP_NNP in_IN
        an_DT attempt_NN to_TO find_VB the_DT '_POS best_JJS '_POS PEEP_NNP ,_, based_VBN on_IN improvement_NN in_IN
        oxygenation_NN ,_, is_VBZ common_JJ practice_NN in_IN the_DT management_NN of_IN
        hypoxaemic_JJ respiratory_JJ failure_NN ._. However_RB ,_, it_PRP is_VBZ unknown_JJ
        whether_IN this_DT strategy_NN has_VBZ an_DT adverse_JJ effect_NN on_IN splanchnic_JJ
        perfusion_NN ._. The_DT aim_NN of_IN the_DT present_JJ study_NN was_VBD to_TO investigate_VB
        the_DT impact_NN of_IN PEEP_NNP titration_NN (_( based_VBN on_IN improvement_NN in_IN
        oxygenation_NN )_) on_IN gastric_JJ mucosal_NN perfusion_NN in_IN patients_NNS with_IN
        ARDS_NNP ,_, as_IN assessed_VBN by_IN measurement_NN of_IN gastric_JJ mucosal_NN pH_NN (_( pH_NN 
        i_NNP )_) ._.
      
      
        Method_NNP
        
          Patients_NNS
          The_DT study_NN protocol_NN was_VBD approved_VBN by_IN the_DT Institutional_NNP
          Ethics_NNP Committee_NNP of_IN Istanbul_NNP University_NNP Hospital_NNP ._. Written_VBN
          informed_VBN consent_NN was_VBD obtained_VBN from_IN each_DT patient_NN or_CC the_DT
          patient_NN 's_POS next_JJ of_IN kin_NN ._. We_PRP consecutively_RB enrolled_VBD 17_CD
          patients_NNS with_IN ARDS_NNP admitted_VBD to_TO the_DT multidisciplinary_JJ
          intensive_JJ care_NN unit_NN at_IN Istanbul_NNP University_NNP Hospital_NNP ._. The_DT
          criteria_NNS for_IN eligibility_NN were_VBD a_DT diagnosis_NN of_IN ARDS_NNP (_( based_VBN
          on_IN a_DT consensus_NN report_NN [_NN 10_CD ]_NN )_) ,_, age_NN older_JJR than_IN 18_CD years_NNS
          and_CC mean_VB arterial_NN pressure_NN (_( MAP_NNP )_) greater_JJR than_IN 60_CD mmHg_NN
          with_IN no_DT haemodynamic_JJ support_NN ._. All_DT patients_NNS were_VBD enrolled_VBN
          within_IN the_DT first_JJ 24_CD hours_NNS following_VBG the_DT diagnosis_NN of_IN
          ARDS_NNP ._. Patients_NNS with_IN known_VBN cardiac_JJ dysfunction_NN or_CC
          pre-existing_JJ liver_NN disease_NN were_VBD not_RB included_VBN in_IN the_DT
          trial_NN ._.
        
        
          Protocol_NNP
          All_DT patients_NNS were_VBD ventilated_VBN using_VBG a_DT Servo_NNP 300_CD Siemens_NNP
          ventilator_NN (_( Siemens_NNP Elema_NNP ,_, Uppsala_NNP ,_, Sweden_NNP )_) using_VBG the_DT
          pressure-regulated_JJ volume_NN control_NN mode_NN with_IN a_DT tidal_JJ
          volume_NN of_IN 8_CD -_: 10_CD ml_NN /_NN kg_NN (_( based_VBN on_IN ideal_JJ body_NN weight_NN )_) ,_,
          frequency_NN of_IN 12_CD breaths_NNS /_NN min_NN ,_, fraction_NN of_IN inspired_VBN oxygen_NN
          of_IN 1_CD ._. 0_CD ,_, and_CC inspiratory_NN :_: expiratory_NN ratio_NN of_IN 1_CD :_: 2_CD ._. Patients_NNS
          were_VBD sedated_JJ with_IN midazolam_NN (_( Dormicum_NNP ;_: Hoffmann_NNP LaRoche_NNP ,_,
          Basel_NNP ,_, Switzerland_NNP )_) at_IN 4_CD mg_NN /_NN hour_NN and_CC paralyzed_VBN with_IN 0_CD ._. 1_CD
          mg_NN /_NN kg_NN vecuronium_NN (_( Norcuron_NNP ;_: Organon_NNP ,_, Oss_NNP ,_, The_DT
          Netherlands_NNP )_) infusion_NN during_IN the_DT study_NN ._. In_IN addition_NN to_TO
          employing_VBG a_DT radial_NN arterial_NN catheter_NN for_IN blood_NN pressure_NN
          measurement_NN ,_, a_DT pulmonary_JJ artery_NN catheter_NN (_( Abbot_NNP labs_NNS ,_,
          North_NNP Chicago_NNP ,_, IL_NNP ,_, USA_NNP )_) was_VBD placed_VBN in_IN all_DT patients_NNS for_IN
          haemodynamic_JJ monitoring_NN ._. No_DT patients_NNS received_VBD any_DT
          therapeutic_JJ intervention_NN to_TO improve_VB haemodynamics_NNS (_( i_NNP ._. e_SYM ._.
          fluid_JJ resuscitation_NN or_CC catecholamine_NN infusion_NN )_) throughout_IN
          the_DT study_NN ._.
          Baseline_NNP PEEP_NNP (_( PEEP_NNP 
          baseline_NN )_) was_VBD set_VBN at_IN 5_CD cmH_NN 
          2_CD O_NNP and_CC titrated_JJ at_IN 2_CD cmH_NN 
          2_CD O_NNP increments_NNS until_IN the_DT partial_JJ
          arterial_NN oxygen_NN tension_NN (_( PaO_NNP 
          2_LS )_) reached_VBN at_IN least_JJS 300_CD mmHg_NN ,_, peak_NN
          airway_NN pressure_NN was_VBD 45_CD cmH_NN 
          2_CD O_NNP or_CC greater_JJR ,_, or_CC MAP_NNP dropped_VBN by_IN 20_CD %_NN
          or_CC more_JJR from_IN the_DT baseline_NN value_NN ._. Criteria_NNP for_IN
          overinflation_NN of_IN lung_NN (_( and_CC therefore_RB for_IN discontinuation_NN
          of_IN further_JJ titration_NN of_IN PEEP_NNP )_) were_VBD reduction_NN in_IN PaO_NNP 
          2_CD of_IN 10_CD %_NN or_CC more_JJR and_CC an_DT increase_NN in_IN
          arterial_NN carbon_NN dioxide_NN tension_NN of_IN 10_CD %_NN or_CC more_JJR ._. Optimal_NNP
          PEEP_NNP (_( PEEP_NNP 
          opt_VB )_) was_VBD defined_VBN as_IN the_DT PEEP_NNP that_WDT
          achieved_VBD the_DT best_JJS oxygenation_NN ,_, whereas_IN maximum_NN PEEP_NNP (_( PEEP_NNP
          
          max_NN )_) was_VBD the_DT greatest_JJS level_NN of_IN PEEP_NNP
          achieved_VBD during_IN titration_NN in_IN each_DT patient_NN ._.
          A_DT nasogastric_JJ catheter_NN (_( TRIP_NNP Catheter_NNP ;_: Tonometrics_NNP
          Division_NNP ,_, Instrumentarium_NNP Corp_NNP ._. ,_, Helsinki_NNP ,_, Finland_NNP )_) was_VBD
          inserted_VBN into_IN the_DT stomach_NN to_TO measure_VB pH_NN 
          i_NNP ._. Correct_NNP placement_NN of_IN the_DT TRIP_NNP
          catheter_NN was_VBD confirmed_VBN by_IN radiography_NN ._. Enteral_NNP nutrition_NN
          was_VBD withheld_VBN throughout_IN the_DT study_NN ,_, and_CC all_DT patients_NNS
          received_VBD ranitidine_NN 50_CD mg_NN intravenously_RB ._. In_IN order_NN to_TO
          allow_VB for_IN equilibration_NN ,_, pH_NN 
          i_NNP was_VBD measured_VBN 45_CD min_NN after_IN injection_NN
          of_IN 2_CD ._. 5_CD ml_NN isotonic_JJ saline_NN into_IN the_DT semipermeable_JJ balloon_NN
          of_IN the_DT TRIP_NNP catheter_NN ._. Partial_NNP pressure_NN of_IN carbon_NN dioxide_NN
          in_IN saline_NN solution_NN and_CC bicarbonate_NN level_NN in_IN arterial_NN
          blood_NN were_VBD measured_VBN simultaneously_RB using_VBG a_DT blood_NN gas_NN
          analyzer_NN (_( ABL-_NNP 500_CD ;_: Radiometer_NNP ,_, Copenhagen_NNP ,_, Denmark_NNP )_)
          immediately_RB after_IN sampling_VBG [_NN 11_CD ]_NN and_CC were_VBD corrected_VBN for_IN
          the_DT equilibration_NN time_NN [_NN 12_CD ]_NN ._. The_DT pH_NN 
          i_NNP was_VBD calculated_VBN using_VBG the_DT
          Henderson-_NNP Hassel-bach_NNP equation_NN ._.
          All_DT measurements_NNS ,_, including_VBG respiratory_JJ ,_, haemodynamic_JJ
          parameters_NNS ,_, arterial_NN and_CC mixed_JJ venous_JJ blood_NN gas_NN analyses_NNS ,_,
          and_CC gastric_JJ pH_NN 
          i_NNP ,_, were_VBD taken_VBN at_IN baseline_NN and_CC
          following_VBG ventilation_NN for_IN 45_CD min_NN at_IN each_DT level_NN of_IN PEEP_NNP ._.
          Haemodynamic_NNP parameters_NNS were_VBD monitored_VBN continuously_RB using_VBG
          an_DT Horizon_NNP XL_NNP monitor_VB (_( Mennen_NNP Medical_NNP Inc_NNP ._. ,_, New_NNP York_NNP ,_, NY_NNP ,_,
          USA_NNP )_) ._. Cardiac_NNP output_NN was_VBD measured_VBN in_IN triplicate_NN by_IN
          thermodilution_NN technique_NN using_VBG 10_CD ml_NN saline_NN solution_NN at_IN
          room_NN temperature_NN ._. Cardiac_NNP index_NN ,_, shunt_NN fraction_NN ,_, oxygen_NN
          delivery_NN (_( DO_NNP 
          2_LS )_) and_CC oxygen_NN consumption_NN were_VBD
          calculated_VBN at_IN baseline_NN and_CC at_IN all_DT PEEP_NNP levels_NNS ._.
        
        
          Statistical_NNP analysis_NN
          Paired_NNP analysis_NN of_IN variance_NN tests_NNS were_VBD used_VBN to_TO analyze_VB
          the_DT differences_NNS between_IN measurements_NNS ._. 
          P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ ._. All_DT values_NNS are_VBP presented_VBN as_IN
          mean_NN ±_NN standard_JJ deviation_NN ._.
        
      
      
        Results_NNS
        A_DT total_NN of_IN 17_CD patients_NNS were_VBD enrolled_VBN in_IN the_DT present_JJ
        study_NN (_( 11_CD male_JJ and_CC 6_CD female_JJ )_) ._. The_DT characteristics_NNS of_IN the_DT
        individual_JJ patients_NNS are_VBP shown_VBN in_IN Table_NNP 1_CD ._. The_DT mean_JJ age_NN of_IN
        the_DT study_NN population_NN was_VBD 47_CD ._. 2_LS ±_NN 19_CD ._. 8_CD ,_, the_DT mean_NN Acute_NNP
        Physiology_NNP and_CC Chronic_NNP Health_NNP Evaluation_NNP II_NNP score_NN was_VBD 19_CD ._. 7_CD
        ±_NN 3_CD ._. 5_CD ,_, and_CC the_DT mean_NN Sequential_NNP Organ_NNP Failure_NN Assessment_NNP
        score_NN was_VBD 6_CD ._. 3_CD ±_NN 1_CD ._. 8_CD ._. By_IN titrating_VBG PEEP_NNP ,_, we_PRP were_VBD able_JJ to_TO
        achieve_VB a_DT mean_NN PEEP_NNP 
        opt_VB of_IN 10_CD ._. 4_LS ±_NN 3_CD ._. 9_CD cmH_NN 
        2_CD O_NNP and_CC a_DT PEEP_NNP 
        max_NN of_IN 13_CD ._. 3_LS ±_NN 2_CD ._. 9_CD cmH_NN 
        2_CD O_NNP (_( 
        P_NN =_SYM 0_CD ._. 0001_CD )_) ._. The_DT highest_JJS PEEP_NNP value_NN
        applied_VBN was_VBD 17_CD cmH_NN 
        2_CD O_NNP ._. Static_NNP compliance_NN improved_VBN slightly_RB
        at_IN PEEP_NNP 
        opt_VB ,_, but_CC this_DT did_VBD not_RB achieve_VB
        statistical_JJ significance_NN (_( 
        P_NN =_SYM 0_CD ._. 84_CD ;_: Table_NNP 2_LS )_) ._. Changes_NNS in_IN peak_NN
        airway_NN and_CC mean_VB airway_NN pressures_NNS at_IN PEEP_NNP 
        baseline_NN ,_, PEEP_NNP 
        opt_VB and_CC PEEP_NNP 
        max_NN were_VBD statistically_RB significant_JJ (_( 
        P_NN <_NN 0_CD ._. 001_CD ;_: Table_NNP 2_LS )_) ._. Reasons_NNS for_IN
        stopping_VBG the_DT titration_NN of_IN PEEP_NNP were_VBD reduction_NN in_IN PaO_NNP 
        2_CD (_( from_IN 20_CD %_NN to_TO 40_CD %_NN ;_: 
        n_NN =_SYM 6_CD )_) ,_, reduction_NN in_IN MAP_NNP (_( from_IN 25_CD %_NN to_TO
        60_CD %_NN ;_: 
        n_NN =_SYM 4_LS )_) ,_, adequate_JJ oxygenation_NN (_( PaO_NNP 
        2_CD 350_CD -_: 450_CD mmHg_NN ;_: 
        n_NN =_SYM 4_LS )_) and_CC excessive_JJ peak_NN upper_JJ
        ariway_NN pressure_NN (_( 
        n_NN =_SYM 3_LS )_) ._.
        Although_IN PEEP_NNP significantly_RB improved_VBD shunt_NN fraction_NN ,_, and_CC
        consequently_RB PaO_NNP 
        2_CD ,_, its_PRP$ greater_JJR effect_NN on_IN cardiac_JJ output_NN
        led_VBN to_TO a_DT reduction_NN in_IN DO_NNP 
        2_CD both_DT at_IN PEEP_NNP 
        opt_VB and_CC PEEP_NNP 
        max_NN ._. However_RB ,_, none_NN of_IN the_DT changes_NNS in_IN
        haemodynamic_JJ parameters_NNS ,_, including_VBG those_DT in_IN central_JJ venous_JJ
        pressure_NN ,_, pulmonary_JJ artery_NN occlusion_NN pressure_NN ,_, cardiac_JJ
        output_NN ,_, cardiac_JJ index_NN and_CC DO_NNP 
        2_CD ,_, achieved_VBD statistical_JJ significance_NN
        (_( Table_NNP 2_CD and_CC Fig_NNP ._. 1_LS )_) ._. PaO_NNP 
        2_CD values_NNS remained_VBD stable_JJ at_IN each_DT level_NN
        of_IN PEEP_NNP ._. The_DT mean_JJ pH_NN 
        i_NNP was_VBD 7_CD ._. 31_CD ±_NN 0_CD ._. 13_CD at_IN baseline_NN and_CC 7_CD ._. 32_CD ±_NN
        0_CD ._. 12_CD at_IN PEEP_NNP 
        opt_VB ;_: it_PRP decreased_VBD to_TO 7_CD ._. 29_CD ±_NN 0_CD ._. 12_CD at_IN
        PEEP_NNP 
        max_NN ,_, but_CC this_DT reduction_NN was_VBD not_RB
        statistically_RB significant_JJ (_( 
        P_NN =_SYM 0_CD ._. 84_CD )_) ._. Similar_JJ to_TO pH_NN 
        i_NNP ,_, alterations_NNS in_IN the_DT gap_NN between_IN
        partial_JJ tissue_NN and_CC arterial_NN carbon_NN dioxide_NN tension_NN (_( P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_LS )_) were_VBD not_RB significant_JJ (_( 
        P_NN =_SYM 0_CD ._. 353_CD )_) ._.
        Although_IN the_DT increase_NN in_IN PEEP_NNP had_VBD no_DT impact_NN on_IN the_DT group_NN
        as_IN a_DT whole_NN ,_, changes_NNS in_IN pH_NN 
        i_NNP and_CC P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD during_IN PEEP_NNP titration_NN differed_VBD between_IN
        individual_JJ patients_NNS (_( Table_NNP 3_LS )_) ._. The_DT pH_NN 
        i_NNP decreased_VBD in_IN eight_CD patients_NNS (_( 47_CD %_NN )_) ,_, it_PRP
        increased_VBD in_IN five_CD (_( 29_CD ._. 4_LS %_NN )_) and_CC it_PRP was_VBD unchanged_JJ in_IN four_CD
        (_( 23_CD ._. 5_LS %_NN )_) at_IN PEEP_NNP 
        opt_VB as_IN compared_VBN with_IN PEEP_NNP 
        baseline_NN ._. The_DT pH_NN 
        i_NNP at_IN PEEP_NNP 
        max_NN was_VBD lower_JJR in_IN 12_CD (_( 70_CD ._. 6_CD %_NN )_) and_CC higher_JJR
        in_IN five_CD (_( 29_CD ._. 4_LS %_NN )_) patients_NNS as_IN compared_VBN with_IN baseline_NN values_NNS ._.
        The_DT P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD values_NNS increased_VBN in_IN nine_CD (_( 52_CD ._. 3_LS %_NN )_)
        patients_NNS at_IN PEEP_NNP 
        opt_VB and_CC in_IN 10_CD (_( 58_CD ._. 3_LS %_NN )_) patients_NNS at_IN PEEP_NNP 
        max_NN as_IN compared_VBN with_IN PEEP_NNP 
        baseline_NN (_( Table_NNP 3_LS )_) ._. However_RB ,_, there_EX were_VBD
        no_DT statistically_RB significant_JJ differences_NNS in_IN P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD values_NNS between_IN PEEP_NNP 
        baseline_NN ,_, PEEP_NNP 
        opt_VB and_CC PEEP_NNP 
        max_NN (_( 
        P_NN =_SYM 0_CD ._. 353_CD ;_: Table_NNP 2_LS )_) ._. Interestingly_RB ,_,
        DO_NNP 
        2_CD in_IN those_DT patients_NNS who_WP exhibited_VBN a_DT rise_NN
        in_IN pHi_NN did_VBD not_RB increase_VB ._. Rather_RB ,_, DO_NNP 
        2_CD in_IN these_DT patients_NNS also_RB decreased_VBD
        (_( although_IN this_DT was_VBD not_RB statistically_RB significant_JJ )_) at_IN PEEP_NNP 
        opt_VB and_CC PEEP_NNP 
        max_NN ,_, to_TO a_DT degree_NN similar_JJ to_TO that_DT in_IN
        patients_NNS who_WP exhibited_VBN a_DT drop_NN in_IN pH_NN 
        i_NNP ._.
      
      
        Discussion_NNP
        The_DT results_NNS of_IN the_DT present_JJ study_NN indicate_VBP that_IN
        incremental_JJ increases_NNS in_IN PEEP_NNP do_VBP not_RB impact_VB on_IN splanchnic_JJ
        perfusion_NN ,_, as_IN assessed_VBN by_IN gastric_JJ tonometry_NN ,_, when_WRB cardiac_JJ
        output_NN (_( and_CC consequently_RB DO_NNP 
        2_LS )_) are_VBP maintained_VBN ._.
        In_IN animals_NNS ,_, PEEP_NNP decreases_NNS hepatosplanchnic_JJ perfusion_NN in_IN
        a_DT dose-dependent_JJ manner_NN ,_, with_IN a_DT limited_JJ effect_NN at_IN PEEP_NNP
        levels_NNS of_IN less_JJR than_IN 10_CD cmH_NN 
        2_CD O_NNP [_NN 2_CD 4_CD 5_CD ]_NN ._. Alterations_NNP in_IN
        splanchnic_JJ blood_NN flow_NN attributed_VBD to_TO PEEP_NNP occur_VB in_IN parallel_JJ
        to_TO those_DT in_IN cardiac_JJ output_NN and_CC consequently_RB can_MD be_VB reversed_VBN
        with_IN restoration_NN of_IN blood_NN pressure_NN [_NN 4_CD 13_CD ]_NN ._. Despite_IN
        experimental_JJ evidence_NN ,_, concerns_NNS regarding_VBG the_DT effects_NNS of_IN
        PEEP_NNP on_IN splanchnic_JJ perfusion_NN remain_VB theoretical_JJ because_IN
        large_JJ studies_NNS in_IN humans_NNS are_VBP lacking_VBG ._. Similarly_RB ,_, in_IN humans_NNS
        without_IN ALI_NNP or_CC ARDS_NNP ,_, PEEP_NNP reduces_VBZ splanchnic_JJ oxygenation_NN
        and_CC this_DT is_VBZ accompanied_VBN by_IN decreases_NNS in_IN cardiac_JJ output_NN ,_,
        albeit_IN with_IN no_DT change_NN in_IN lactate_NN levels_NNS [_NN 14_CD ]_NN ._. Recently_RB ,_,
        Kiefer_NNP and_CC colleagues_NNS [_NN 9_CD ]_NN reported_VBD no_DT change_NN in_IN
        splanchnic_JJ perfusion_NN when_WRB PEEP_NNP was_VBD titrated_JJ on_IN the_DT linear_JJ
        portion_NN of_IN the_DT pressure-volume_JJ curve_NN in_IN patients_NNS with_IN ALI_NNP [_NN
        9_CD ]_NN ._.
        The_DT results_NNS presented_VBN here_RB ,_, which_WDT demonstrate_VBP a_DT lack_NN of_IN
        impact_NN on_IN splanchnic_JJ blood_NN flow_NN when_WRB PEEP_NNP is_VBZ not_RB
        accompanied_VBN by_IN decreased_VBD cardiac_JJ output_NN ,_, corroborate_VBP those_DT
        from_IN animal_NN studies_NNS [_NN 4_CD 13_CD ]_NN and_CC from_IN the_DT recent_JJ human_JJ
        study_NN conducted_VBN by_IN Kiefer_NNP and_CC coworkers_NNS [_NN 9_CD ]_NN ._. The_DT lack_NN of_IN
        change_NN in_IN pH_NN 
        i_NNP at_IN PEEP_NNP 
        opt_VB (_( 11_CD cmH_NN 
        2_CD O_NNP )_) is_VBZ in_IN agreement_NN with_IN our_PRP$ current_JJ
        understanding_NN that_IN PEEP_NNP at_IN 10_CD cmH_NN 
        2_CD O_NNP has_VBZ a_DT limited_JJ effect_NN on_IN splanchnic_JJ
        blood_NN flow_NN ._. Furthermore_RB ,_, the_DT presence_NN of_IN ARDS_NNP limited_VBD the_DT
        relative_JJ impact_NN of_IN increased_VBN thoracic_JJ pressure_NN on_IN the_DT
        cardiovascular_JJ system_NN ._.
        Perhaps_RB more_RBR important_JJ ,_, these_DT observations_NNS were_VBD valid_JJ
        for_IN a_DT wide_JJ range_NN of_IN PEEP_NNP levels_NNS ,_, from_IN 5_CD cmH_NN 
        2_CD O_NNP to_TO as_RB high_JJ as_IN 17_CD cmH_NN 
        2_CD O_NNP ._. We_PRP ascribed_VBN the_DT lack_NN of_IN significant_JJ
        changes_NNS in_IN cardiac_JJ output_NN and_CC DO_NNP 
        2_CD in_IN the_DT patients_NNS to_TO adequate_JJ volume_NN
        status_NN and_CC preload_NN ._. Relative_NNP hypovolaemia_NN appears_VBZ to_TO be_VB the_DT
        most_RBS likely_JJ explanation_NN for_IN the_DT reductions_NNS in_IN cardiac_JJ
        output_NN and_CC splanchnic_JJ blood_NN flow_NN observed_VBD in_IN animal_NN
        studies_NNS ._. Gastric_NNP pH_NN 
        i_NNP ,_, and_CC consequently_RB splanchnic_JJ blood_NN
        flow_NN ,_, remained_VBD stable_JJ at_IN PEEP_NNP 
        opt_VB and_CC PEEP_NNP 
        max_NN when_WRB cardiac_JJ output_NN and_CC DO_NNP 2_CD remained_VBD
        relatively_RB unchanged_JJ ._. Preservation_NNP of_IN splanchnic_JJ blood_NN flow_NN
        at_IN PEEP_NNP 
        opt_VB and_CC PEEP_NNP 
        max_NN was_VBD attributed_VBN to_TO an_DT increase_NN in_IN
        oxygen_NN extraction_NN ratio_NN that_WDT was_VBD sufficient_JJ to_TO compensate_VB
        for_IN the_DT small_JJ ,_, insignificant_JJ drop_NN in_IN cardiac_JJ output_NN and_CC DO_NNP 
        2_CD that_WDT occurred_VBD during_IN PEEP_NNP titration_NN [_NN
        15_CD ]_NN ._.
        It_PRP is_VBZ also_RB noteworthy_JJ that_IN there_EX may_MD be_VB individual_JJ
        variations_NNS in_IN pH_NN 
        i_NNP in_IN response_NN to_TO PEEP_NNP ._. Although_IN
        differences_NNS in_IN pH_NN 
        i_NNP response_NN among_IN individuals_NNS cannot_NN
        explained_VBD on_IN the_DT basis_NN of_IN changes_NNS in_IN DO_NNP 
        2_CD ,_, they_PRP may_MD be_VB attributed_VBN to_TO
        differences_NNS in_IN the_DT relative_JJ impact_NN of_IN underlying_VBG critical_JJ
        illness_NN on_IN splanchnic_JJ perfusion_NN and_CC variations_NNS in_IN
        splanchnic_JJ vascular_NN response_NN (_( i_NNP ._. e_SYM ._. severity_NN and_CC /_NN or_CC duration_NN
        of_IN vasoconstriction_NN ,_, extraction_NN ratio_NN )_) to_TO small_JJ changes_NNS in_IN
        DO_NNP 
        2_CD among_IN individuals_NNS ._.
        Because_IN of_IN concerns_NNS about_IN the_DT reliability_NN of_IN pH_NN 
        i_NNP for_IN assessing_VBG mucosal_NN perfusion_NN ,_, we_PRP
        also_RB calculated_VBD the_DT P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD because_IN it_PRP has_VBZ been_VBN proposed_VBN to_TO be_VB a_DT
        better_JJR parameter_NN than_IN pH_NN 
        i_NNP [_NN 16_CD ]_NN ._. The_DT pH_NN 
        i_NNP level_NN can_MD sometimes_RB be_VB misleading_JJ ,_,
        particularly_RB in_IN situations_NNS in_IN which_WDT gastric_JJ tissue_NN and_CC
        arterial_NN bicarbonate_NN levels_NNS are_VBP not_RB equal_JJ ._. In_IN addition_NN ,_,
        unlike_IN pH_NN 
        i_NNP ,_, which_WDT can_MD change_VB with_IN the_DT degree_NN of_IN
        alveolar_NN ventilation_NN ,_, P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD remains_VBZ a_DT reliable_JJ parameter_NN because_IN
        both_DT components_NNS (_( i_NNP ._. e_SYM ._. partial_JJ arterial_NN and_CC tissue_NN carbon_NN
        dioxide_NN tension_NN )_) are_VBP similarly_RB influenced_VBN by_IN changes_NNS in_IN
        alveolar_NN ventilation_NN ,_, unless_IN they_PRP are_VBP associated_VBN with_IN
        alterations_NNS in_IN cardiac_JJ output_NN [_NN 17_CD ]_NN ._. In_IN the_DT present_JJ
        study_NN ,_, changes_NNS in_IN P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD were_VBD not_RB statistically_RB significant_JJ and_CC
        correlated_JJ with_IN changes_NNS in_IN pH_NN 
        i_NNP ._. Consequently_RB ,_, we_PRP used_VBD pHi_NN values_NNS in_IN
        our_PRP$ discussion_NN because_IN we_PRP believe_VBP that_DT pH_NN 
        i_NNP reliably_RB reflects_VBZ the_DT accurate_JJ tissue_NN
        pH_NN in_IN patients_NNS ._.
        Our_PRP$ results_NNS corroborate_VBP those_DT from_IN the_DT only_RB other_JJ study_NN
        that_WDT evaluated_VBD the_DT impact_NN of_IN PEEP_NNP on_IN splanchnic_JJ perfusion_NN
        in_IN patients_NNS with_IN ALI_NNP ._. Similar_JJ to_TO Kiefer_NNP and_CC colleagues_NNS [_NN 9_CD
        ]_NN ,_, we_PRP found_VBD no_DT change_NN either_CC in_IN pH_NN 
        i_NNP or_CC P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD during_IN PEEP_NNP titration_NN ._. However_RB ,_, there_EX
        were_VBD several_JJ differences_NNS between_IN two_CD studies_NNS ._. Whereas_IN
        Kiefer_NNP and_CC colleagues_NNS used_VBD pressure-volume_JJ curves_NNS for_IN PEEP_NNP
        titration_NN ,_, we_PRP titrated_JJ PEEP_NNP on_IN the_DT basis_NN of_IN improvement_NN in_IN
        oxygenation_NN ,_, which_WDT is_VBZ a_DT commonly_RB used_VBN method_NN in_IN clinical_JJ
        practice_NN because_IN determination_NN of_IN pressure-volume_JJ curves_NNS
        can_MD sometimes_RB be_VB cumbersome_JJ ._. Furthermore_RB ,_, the_DT present_JJ study_NN
        was_VBD larger_JJR and_CC we_PRP included_VBD patients_NNS with_IN more_RBR severe_JJ
        disease_NN (_( ratio_NN of_IN fractional_JJ inspired_VBN oxygen_NN to_TO PaO_NNP 
        2_CD :_: 139_CD in_IN the_DT present_JJ study_NN versus_CC 168_CD
        in_IN that_DT conducted_VBN by_IN Kiefer_NNP and_CC coworkers_NNS )_) ._.
        However_RB ,_, the_DT present_JJ study_NN has_VBZ several_JJ limitations_NNS ._. The_DT
        first_JJ and_CC perhaps_RB most_RBS important_JJ limitation_NN of_IN the_DT study_NN is_VBZ
        the_DT liberal_JJ titration_NN of_IN PEEP_NNP in_IN order_NN to_TO determine_VB its_PRP$
        impact_NN on_IN pH_NN 
        i_NNP ,_, as_IN described_VBN under_IN Method_NNP (_( see_VB
        above_IN )_) ._. We_PRP acknowledge_VBP that_IN in_IN day-to-day_JJ clinical_JJ
        practice_NN ,_, some_DT of_IN the_DT patients_NNS would_MD not_RB have_VB been_VBN managed_VBN
        with_IN such_JJ aggressive_JJ titration_NN of_IN PEEP_NNP and_CC therefore_RB would_MD
        not_RB have_VB received_VBN the_DT levels_NNS of_IN PEEP_NNP achieved_VBD in_IN the_DT study_NN ,_,
        rendering_VBG the_DT clinical_JJ implications_NNS of_IN these_DT observations_NNS
        quite_RB limited_JJ ._. Second_JJ ,_, we_PRP did_VBD not_RB directly_RB measure_VB
        splanchnic_JJ perfusion_NN but_CC assessed_VBD it_PRP indirectly_RB by_IN
        monitoring_VBG pH_NN 
        i_NNP using_VBG gastric_JJ tonometry_NN ._. Although_IN the_DT
        diagnostic_JJ value_NN of_IN gastric_JJ tonometry_NN has_VBZ been_VBN questioned_VBN
        because_IN some_DT methodological_JJ problems_NNS ,_, we_PRP believe_VBP that_IN we_PRP
        minimized_VBN most_JJS of_IN these_DT limitations_NNS and_CC improved_VBD the_DT
        reproducibility_NN of_IN our_PRP$ measurements_NNS by_IN immediate_JJ analysis_NN
        of_IN samples_NNS ,_, use_NN of_IN H_NNP 
        2_CD blockers_NNS [_NN 18_CD ]_NN and_CC lack_NN of_IN enteral_NN
        nutrition_NN [_NN 19_CD ]_NN ,_, rendering_VBG it_PRP possible_JJ to_TO use_VB gastric_JJ pH_NN 
        i_NNP to_TO evaluate_VB splanchnic_JJ perfusion_NN ._.
        Third_NNP ,_, PEEP_NNP 
        opt_VB in_IN the_DT study_NN (_( approximately_RB 11_CD cmH_NN 
        2_CD O_NNP )_) was_VBD lower_JJR than_IN levels_NNS reported_VBD in_IN
        other_JJ ARDS_NNP studies_NNS [_NN 20_CD ]_NN ._. Higher_JJR tidal_JJ volume_NN (_( 10_CD ml_NN /_NN kg_NN )_)
        leading_VBG to_TO higher_JJR mean_NN airway_NN pressure_NN ,_, the_DT termination_NN
        criteria_NNS used_VBN in_IN our_PRP$ study_NN ,_, and_CC the_DT differences_NNS in_IN
        titration_NN technique_NN (_( based_VBN on_IN oxygenation_NN versus_CC
        pressure-volume_JJ curve_NN )_) may_MD account_VB for_IN this_DT difference_NN ._.
        Finally_RB ,_, pH_NN 
        i_NNP was_VBD measured_VBN after_IN patients_NNS had_VBD been_VBN
        exposed_VBN to_TO different_JJ levels_NNS of_IN PEEP_NNP for_IN a_DT short_JJ duration_NN ._.
        Although_IN short-term_JJ application_NN of_IN high_JJ PEEP_NNP did_VBD not_RB
        significantly_RB change_VB pH_NN 
        i_NNP ,_, it_PRP is_VBZ conceivable_JJ that_IN longer_JJR
        durations_NNS or_CC higher_JJR numbers_NNS of_IN patients_NNS would_MD have_VB led_VBN to_TO
        more_RBR prominent_JJ reductions_NNS and_CC statistically_RB significant_JJ
        differences_NNS ._.
        Collectively_RB ,_, the_DT present_JJ findings_NNS indicate_VBP that_DT
        determination_NN of_IN PEEP_NNP 
        opt_VB by_IN titration_NN of_IN PEEP_NNP based_VBN on_IN
        improvement_NN in_IN oxygenation_NN is_VBZ a_DT safe_JJ strategy_NN ,_, with_IN no_DT
        impairment_NN in_IN gastric_JJ mucosal_NN perfusion_NN ,_, when_WRB cardiac_JJ
        output_NN is_VBZ preserved_VBN ._. Maintenance_NNP of_IN cardiac_JJ output_NN during_IN
        mechanical_JJ ventilation_NN with_IN high_JJ PEEP_NNP may_MD be_VB adequate_JJ to_TO
        prevent_VB its_PRP$ unwanted_JJ effects_NNS on_IN organs_NNS in_IN the_DT splanchnic_JJ
        vasculature_NN ._. Nonetheless_RB ,_, the_DT possibility_NN that_IN PEEP_NNP can_MD
        alter_VB splanchnic_JJ perfusion_NN when_WRB it_PRP is_VBZ applied_VBN at_IN high_JJ
        levels_NNS and_CC for_IN longer_JJR durations_NNS cannot_NN be_VB completely_RB
        excluded_VBN ._.
      
      
        Key_JJ message_NN
        •_NN Incremental_NNP increase_NN in_IN PEEP_NNP to_TO identify_VB the_DT optimal_NN
        value_NN does_VBZ not_RB affect_VB splanchnic_JJ perfusion_NN as_IN assessed_VBN by_IN
        gastric_JJ tonometry_NN
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        ALI_NNP =_SYM acute_JJ lung_NN injury_NN ;_: ARDS_NNP =_SYM acute_JJ respiratory_JJ
        distress_NN syndrome_NN ;_: DO_NNP 
        2_CD =_SYM oxygen_NN delivery_NN ;_: MAP_NNP =_SYM mean_VB arterial_NN
        pressure_NN ;_: Pao_NNP 
        2_CD =_SYM partial_JJ arterial_NN oxygen_NN tension_NN ;_: P_NN 
        (_( t-a_JJ )_) CO_NNP 
        2_CD =_SYM gap_NN between_IN partial_JJ tissue_NN and_CC
        arterial_NN carbon_NN dioxide_NN tension_NN ;_: PEEP_NNP =_SYM positive_JJ
        end-expiratory_JJ pressure_NN ;_: pH_NN 
        i_NNP =_SYM gastric_JJ mucosal_NN pH_NN ._.
      
    
  
